This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Dr. James Brandt on New Horizons in Glaucoma Drug Delivery

James D. Brandt, MD co-moderated the session “New Horizons in Glaucoma Drug Delivery” with Anne L. Coleman, MD, PhD at the 7th annual Glaucoma 360 New Horizons Forum in San Francisco.

Catalyst for a Cure 2018 Research Progress Report

Biomarkers can provide physicians with better tools to diagnose and manage glaucoma before vision is lost, as well as accelerate better treatments for glaucoma.

Dr. Janey Wiggs: Update on Genetic Research for Glaucoma

We talked with Dr. Janey Wiggs, a scientific advisor for Glaucoma Research Foundation, at the AAO 2017 meeting in New Orleans about what’s new in genetic research for treating glaucoma.

2018 Glaucoma Research Update: Dr. Andrew Huberman’s Laboratory

Andrew Huberman, PhD is a principal investigator in the Catalyst for a Cure Biomarkers Team funded by Glaucoma Research Foundation in San Francisco, CA.

2018 Glaucoma Research Update: Vivek Srinivasan’s Laboratory

The Srinivasan Laboratory at the University of California, Davis, develops novel optical imaging techniques and diagnostics with applications spanning from basic to clinical research.

2018 Glaucoma Research Update: Dr. Jeffrey Goldberg’s Laboratory at Stanford

Dr. Goldberg’s glaucoma research is directed at neuroprotection and regeneration of retinal ganglion cells and other retinal neurons.

Why Retinal Ganglion Cells Are Important in Glaucoma

Retinal ganglion cells (RGCs) are particularly important in glaucoma because they are the cells that are damaged by the disease.

Spotlight on Research: Dr. Alfredo Dubra’s Laboratory at Stanford

“We’re not just trying to achieve some answer in terms of scientific curiosity, but our aim is to really help people who are suffering from this disease.” — Alfredo Dubra, PhD

Scientists Discover New Potential Glaucoma Treatment

Vision scientists have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma.

Researcher Spotlight: Andrew Huberman, PhD

Researchers like Dr. Andrew Huberman and the other Catalyst for a Cure scientists are focused on stopping blindness from glaucoma.

Dr. John Flanagan Joins Glaucoma Research Foundation Board and Continues Shaffer Grant Research

Dr. John Flanagan is actively working on research to discover new ways to treat glaucoma.

Dr. Elizabeth Fini Receives NIH Funding for Glaucoma Research, Thanks to GRF Shaffer Grant

Glaucoma Research Foundation (GRF) is dedicated to supporting promising research conducted by dedicated scientists.

A Practical Guide To The Best Medical Research Charities

If you’re looking for a medical research charity to support, you probably want to know with confidence that your donation is going to make an impact and help people.

New Nanoparticle Drug Delivery Can Help Enhance Glaucoma Treatments

Evidence is building that nanoparticles will prove an excellent drug delivery system, and it won’t be long until this technology reaches patients.

How Sleep Apnea May Contribute to Normal-Tension Glaucoma Risk

By using a new contact lens technology, researchers are hoping to gain new insight into obstructive sleep apnea by continuously monitoring the eye pressure even during sleep cycles.

Exosomes in the Retina Could Be Used To Treat Glaucoma

Recently, the National Eye Institute released an optimistic report stating that exosomes secreted by stem cells are protective to the retina.

Innovative Research Leading to a Cure

Through the Shaffer Grants, Glaucoma Research Foundation invests in a wide variety of projects that increase scientific understanding of glaucoma.

Role of Antioxidants for Future Glaucoma Treatment Possibilities and Patient Options

Since oxidative stress is associated with damage to the optic nerve in glaucoma, you may wonder whether you should be increasing the antioxidants in your diet.

Zinc in the Retina May Indicate A New Way to Protect and Regenerate the Optic Nerve in Glaucoma Patients

Connecting pieces of information by finding a common thread often takes glaucoma researchers in unexpected directions.

Polymer Ring Drug Delivery System for Non-invasive Treatment in Early Glaucoma Patients

Using an insert, it should be possible to deliver a consistent dose of medication to the eye while reducing the initial sting or burn, with less of the medication lost to the tear duct or sinuses.

Catalyst for a Cure Biomarker Initiative: A Game Changer in the Fight to Protect Vision

“Two clinical trials are underway for vision restoration,” says Dr. Huberman. “These trials would not be possible without the identification of new biomarkers.”

Catalyst for a Cure Research Progress: Biomarker Initiative

Glaucoma Research Foundation established the Catalyst for a Cure Biomarker Initiative to help glaucoma patients preserve their vision.

Using Cataract Surgery to Treat Glaucoma Could Be the Next Step to a More Effective Treatment for PCAG

There is evidence that the lens extraction and replacement method used for cataract treatment may be a viable option for primary closed-angle glaucoma as well.

New Research Can Help Find Solutions to the Challenge of Glaucoma in Developing Countries

Glaucoma in developing countries represents a significant health crisis.

New Research Suggests A Breakthrough In Understanding Normal Tension Glaucoma

Researchers are still in the early stages of exploring how this information can be turned into new glaucoma treatments.